NFKB1 and hepatocellular carcinoma: The inhibition of NF-κB activity is closely related to its anti-cancer, anti-resistance, and apoptosis activities in various cancer cells, such as hepatocellular carcinoma and leukemic cancer cells (Foo and Nolan, 1999[9]; Arsura and Cavin, 2005[3]; Wang et al., 2010[40]).